Litcius/Paper detail

Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency

Anna-Lisa Lanz, Martin Bernhard Riester, Philipp Peters, Tobias Schwerd, Eberhard Lurz, Mohammad Hajji, Meino Rohlfs, Julia Ley‐Zaporozhan, Christoph Walz, Daniel Kotlarz, Christoph Klein, Michael H. Albert, Fabian Hauck

2021Clinical Immunology35 citationsDOI

Topics & Concepts

AbataceptHaploinsufficiencyMedicineRefractory (planetary science)Immune dysregulationInternal medicineImmunologyRituximabDiseaseAntibodyGenePhysicsBiochemistryPhenotypeChemistryAstrobiologyImmunodeficiency and Autoimmune DisordersBlood disorders and treatmentsPlatelet Disorders and Treatments
Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency | Litcius